🎉 M&A multiples are live!
Check it out!

Phibro Animal Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Phibro Animal Health and similar public comparables like Pharming, Galapagos, and Vivoryon Therapeutics.

Phibro Animal Health Overview

About Phibro Animal Health

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.


Founded

2014

HQ

United States of America
Employees

1.9K+

Website

pahc.com

Financials

LTM Revenue $1.2B

LTM EBITDA $158M

EV

$1.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Phibro Animal Health Financials

Phibro Animal Health has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $158M.

In the most recent fiscal year, Phibro Animal Health achieved revenue of $1.0B and an EBITDA of $69.1M.

Phibro Animal Health expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Phibro Animal Health valuation multiples based on analyst estimates

Phibro Animal Health P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $978M $1.0B XXX XXX XXX
Gross Profit $285M $298M XXX XXX XXX
Gross Margin 29% 29% XXX XXX XXX
EBITDA $106M $69.1M XXX XXX XXX
EBITDA Margin 11% 7% XXX XXX XXX
Net Profit $49.2M $32.6M XXX XXX XXX
Net Margin 5% 3% XXX XXX XXX
Net Debt $359M $434M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Phibro Animal Health Stock Performance

As of April 15, 2025, Phibro Animal Health's stock price is $18.

Phibro Animal Health has current market cap of $725M, and EV of $1.4B.

See Phibro Animal Health trading valuation data

Phibro Animal Health Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.4B $725M XXX XXX XXX XXX $1.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Phibro Animal Health Valuation Multiples

As of April 15, 2025, Phibro Animal Health has market cap of $725M and EV of $1.4B.

Phibro Animal Health's trades at 1.2x LTM EV/Revenue multiple, and 9.2x LTM EBITDA.

Analysts estimate Phibro Animal Health's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Phibro Animal Health and 10K+ public comps

Phibro Animal Health Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.4B XXX XXX XXX
EV/Revenue 1.3x XXX XXX XXX
EV/EBITDA 12.1x XXX XXX XXX
P/E 27.7x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF 34.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Phibro Animal Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Phibro Animal Health Valuation Multiples

Phibro Animal Health's NTM/LTM revenue growth is 11%

Phibro Animal Health's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Phibro Animal Health's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Phibro Animal Health's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Phibro Animal Health and other 10K+ public comps

Phibro Animal Health Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 4% XXX XXX XXX XXX
EBITDA Margin 11% XXX XXX XXX XXX
EBITDA Growth -35% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 22% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 26% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Phibro Animal Health Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Phibro Animal Health M&A and Investment Activity

Phibro Animal Health acquired  XXX companies to date.

Last acquisition by Phibro Animal Health was  XXXXXXXX, XXXXX XXXXX XXXXXX . Phibro Animal Health acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Phibro Animal Health

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Phibro Animal Health

When was Phibro Animal Health founded? Phibro Animal Health was founded in 2014.
Where is Phibro Animal Health headquartered? Phibro Animal Health is headquartered in United States of America.
How many employees does Phibro Animal Health have? As of today, Phibro Animal Health has 1.9K+ employees.
Who is the CEO of Phibro Animal Health? Phibro Animal Health's CEO is Mr. Jack Clifford Bendheim.
Is Phibro Animal Health publicy listed? Yes, Phibro Animal Health is a public company listed on NAS.
What is the stock symbol of Phibro Animal Health? Phibro Animal Health trades under PAHC ticker.
When did Phibro Animal Health go public? Phibro Animal Health went public in 2014.
Who are competitors of Phibro Animal Health? Similar companies to Phibro Animal Health include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Phibro Animal Health? Phibro Animal Health's current market cap is $725M
What is the current revenue of Phibro Animal Health? Phibro Animal Health's last 12-month revenue is $1.2B.
What is the current EBITDA of Phibro Animal Health? Phibro Animal Health's last 12-month EBITDA is $158M.
What is the current EV/Revenue multiple of Phibro Animal Health? Current revenue multiple of Phibro Animal Health is 1.2x.
What is the current EV/EBITDA multiple of Phibro Animal Health? Current EBITDA multiple of Phibro Animal Health is 9.2x.
What is the current revenue growth of Phibro Animal Health? Phibro Animal Health revenue growth between 2023 and 2024 was 4%.
Is Phibro Animal Health profitable? Yes, Phibro Animal Health is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.